QQQ   279.76 (-0.79%)
AAPL   145.43 (-0.66%)
MSFT   246.79 (-0.97%)
META   139.07 (+0.06%)
GOOGL   101.42 (+-0.01%)
AMZN   120.30 (-0.54%)
TSLA   238.13 (-1.11%)
NVDA   131.30 (-0.60%)
NIO   14.77 (-7.92%)
BABA   84.32 (-0.08%)
AMD   67.85 (-0.13%)
T   15.32 (-3.83%)
MU   54.62 (-0.20%)
CGC   3.75 (+22.15%)
F   12.36 (-1.20%)
GE   66.22 (-1.81%)
DIS   100.04 (-0.75%)
AMC   7.12 (-2.86%)
PYPL   94.42 (+0.63%)
PFE   43.09 (-2.33%)
NFLX   240.02 (+1.39%)
QQQ   279.76 (-0.79%)
AAPL   145.43 (-0.66%)
MSFT   246.79 (-0.97%)
META   139.07 (+0.06%)
GOOGL   101.42 (+-0.01%)
AMZN   120.30 (-0.54%)
TSLA   238.13 (-1.11%)
NVDA   131.30 (-0.60%)
NIO   14.77 (-7.92%)
BABA   84.32 (-0.08%)
AMD   67.85 (-0.13%)
T   15.32 (-3.83%)
MU   54.62 (-0.20%)
CGC   3.75 (+22.15%)
F   12.36 (-1.20%)
GE   66.22 (-1.81%)
DIS   100.04 (-0.75%)
AMC   7.12 (-2.86%)
PYPL   94.42 (+0.63%)
PFE   43.09 (-2.33%)
NFLX   240.02 (+1.39%)
QQQ   279.76 (-0.79%)
AAPL   145.43 (-0.66%)
MSFT   246.79 (-0.97%)
META   139.07 (+0.06%)
GOOGL   101.42 (+-0.01%)
AMZN   120.30 (-0.54%)
TSLA   238.13 (-1.11%)
NVDA   131.30 (-0.60%)
NIO   14.77 (-7.92%)
BABA   84.32 (-0.08%)
AMD   67.85 (-0.13%)
T   15.32 (-3.83%)
MU   54.62 (-0.20%)
CGC   3.75 (+22.15%)
F   12.36 (-1.20%)
GE   66.22 (-1.81%)
DIS   100.04 (-0.75%)
AMC   7.12 (-2.86%)
PYPL   94.42 (+0.63%)
PFE   43.09 (-2.33%)
NFLX   240.02 (+1.39%)
QQQ   279.76 (-0.79%)
AAPL   145.43 (-0.66%)
MSFT   246.79 (-0.97%)
META   139.07 (+0.06%)
GOOGL   101.42 (+-0.01%)
AMZN   120.30 (-0.54%)
TSLA   238.13 (-1.11%)
NVDA   131.30 (-0.60%)
NIO   14.77 (-7.92%)
BABA   84.32 (-0.08%)
AMD   67.85 (-0.13%)
T   15.32 (-3.83%)
MU   54.62 (-0.20%)
CGC   3.75 (+22.15%)
F   12.36 (-1.20%)
GE   66.22 (-1.81%)
DIS   100.04 (-0.75%)
AMC   7.12 (-2.86%)
PYPL   94.42 (+0.63%)
PFE   43.09 (-2.33%)
NFLX   240.02 (+1.39%)
NASDAQ:APTX

Aptinyx - APTX Stock Forecast, Price & News

$0.35
-0.01 (-2.75%)
(As of 10/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.35
$0.40
50-Day Range
$0.35
$0.69
52-Week Range
$0.33
$3.76
Volume
278,552 shs
Average Volume
361,526 shs
Market Capitalization
$23.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

Aptinyx MarketRank™ Forecast

Analyst Rating
Hold
2.44 Rating Score
Upside/​Downside
747.5% Upside
$3.00 Price Target
Short Interest
Healthy
0.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of Aptinyx in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.02) to ($0.74) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.33 out of 5 stars

Medical Sector

175th out of 1,075 stocks

Pharmaceutical Preparations Industry

65th out of 537 stocks

APTX stock logo

About Aptinyx (NASDAQ:APTX) Stock

Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.

Receive APTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptinyx and its competitors with MarketBeat's FREE daily newsletter.

APTX Stock News Headlines

Brokerages Set Aptinyx Inc. (NASDAQ:APTX) Target Price at $2.60
Aptinyx Inc. (APTX)
What 4 Analyst Ratings Have To Say About Aptinyx
See More Headlines
Receive APTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptinyx and its competitors with MarketBeat's FREE daily newsletter.

APTX Company Calendar

Last Earnings
8/04/2022
Today
10/06/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:APTX
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.00
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
+747.5%
Consensus Rating
Hold
Rating Score (0-4)
2.44
Research Coverage
9 Analysts

Profitability

Net Income
$-74,890,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1 million
Book Value
$1.40 per share

Miscellaneous

Free Float
61,026,000
Market Cap
$23.97 million
Optionable
Not Optionable
Beta
1.24

Key Executives

  • Andrew Kidd
    President, Chief Executive Officer & Director
  • Ashish KhannaAshish Khanna
    Chief Financial & Business Officer
  • Sandip K. Agarwala
    Board Observer
  • Kathryn King
    Senior Vice President-Clinical & CMC Operations
  • Patrick Flavin
    Head-Investor Relations













APTX Stock - Frequently Asked Questions

Should I buy or sell Aptinyx stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aptinyx in the last twelve months. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" APTX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APTX, but not buy additional shares or sell existing shares.
View APTX analyst ratings
or view top-rated stocks.

What is Aptinyx's stock price forecast for 2022?

9 Wall Street analysts have issued twelve-month price targets for Aptinyx's shares. Their APTX share price forecasts range from $1.00 to $5.00. On average, they predict the company's share price to reach $3.00 in the next year. This suggests a possible upside of 710.8% from the stock's current price.
View analysts price targets for APTX
or view top-rated stocks among Wall Street analysts.

How have APTX shares performed in 2022?

Aptinyx's stock was trading at $2.67 on January 1st, 2022. Since then, APTX stock has decreased by 86.1% and is now trading at $0.37.
View the best growth stocks for 2022 here
.

When is Aptinyx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our APTX earnings forecast
.

How were Aptinyx's earnings last quarter?

Aptinyx Inc. (NASDAQ:APTX) announced its quarterly earnings data on Thursday, August, 4th. The company reported ($0.26) earnings per share for the quarter, topping analysts' consensus estimates of ($0.29) by $0.03. During the same quarter last year, the business posted ($0.29) earnings per share.

What other stocks do shareholders of Aptinyx own?
When did Aptinyx IPO?

(APTX) raised $77 million in an IPO on Thursday, June 21st 2018. The company issued 5,300,000 shares at $14.00-$15.00 per share. J.P. Morgan, Cowen, Leerink Partners and BMO Capital Markets acted as the underwriters for the IPO.

What is Aptinyx's stock symbol?

Aptinyx trades on the NASDAQ under the ticker symbol "APTX."

How do I buy shares of Aptinyx?

Shares of APTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aptinyx's stock price today?

One share of APTX stock can currently be purchased for approximately $0.37.

How much money does Aptinyx make?

Aptinyx (NASDAQ:APTX) has a market capitalization of $25.06 million and generates $1 million in revenue each year. The company earns $-74,890,000.00 in net income (profit) each year or ($1.15) on an earnings per share basis.

How can I contact Aptinyx?

Aptinyx's mailing address is 909 DAVIS STREET SUITE 600, EVANSTON IL, 60201. The official website for the company is www.aptinyx.com. The company can be reached via phone at (847) 871-0377 or via email at investors@aptinyx.com.

This page (NASDAQ:APTX) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.